Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
4.290
+0.190 (4.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $6.62 million as of December 20, 2024. Its market cap has increased by 3.37% in one year.
Market Cap
6.62M
Enterprise Value
-223.78K
1-Year Change
3.37%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $6.62M, a decrease of -86.13%. That is a compound annual growth rate of -20.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 6.60M | 24.53% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Star Equity Holdings | 6.95M |
| Vincerx Pharma | 6.95M |
| Adial Pharmaceuticals | 6.85M |
| Kindly MD | 6.69M |
| Portage Biotech | 6.68M |
| GRI Bio | 6.61M |
| Syra Health | 6.58M |
| Plus Therapeutics | 6.43M |